Rockefeller Capital Management L.P. Karyopharm Therapeutics Inc. Transaction History

Rockefeller Capital Management L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.15 - $8.37 $10,375 - $20,924	-2,500 Reduced 73.53%	900 $4,000
Q1 2022 May 13, 2022	SELL	$5.91 - $14.38 $4,137 - $10,066	-700 Reduced 17.07%	3,400 $25,000
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $2,084 - $3,444	400 Added 10.81%	4,100 $26,000
Q3 2021 Nov 12, 2021	BUY	$4.45 - $10.63 $1,335 - $3,189	300 Added 8.82%	3,700 $21,000
Q1 2021 May 11, 2021	BUY	$9.85 - $17.69 $11,820 - $21,228	1,200 Added 54.55%	3,400 $35,000
Q4 2020 Feb 12, 2021	BUY	$14.15 - $17.19 $27,394 - $33,279	1,936 Added 733.33%	2,200 $34,000
Q3 2020 Nov 13, 2020	BUY	$14.14 - $19.71 $1,371 - $1,911	97 Added 58.08%	264 $3,000
Q2 2020 Aug 12, 2020	BUY	$16.6 - $25.25 $2,772 - $4,216	167 New	167 $3,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.